摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

dibenzo[b,j][1,10]phenanthroline | 223-20-1

中文名称
——
中文别名
——
英文名称
dibenzo[b,j][1,10]phenanthroline
英文别名
bisbenzo[2,3:9,8]-1,10-phenanthroline;quinolino[3,2-c]acridine
dibenzo[b,j][1,10]phenanthroline化学式
CAS
223-20-1
化学式
C20H12N2
mdl
——
分子量
280.329
InChiKey
QXVXTSSGCAPNQP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    544.1±23.0 °C(Predicted)
  • 密度:
    1.320±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.8
  • 重原子数:
    22
  • 可旋转键数:
    0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    25.8
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] RHENIUM COMPLEXES AND METHODS OF USE FOR TREATING CANCER<br/>[FR] COMPLEXES DE RHÉNIUM ET MÉTHODES D'UTILISATION POUR LE TRAITEMENT DU CANCER
    申请人:UNIV CORNELL
    公开号:WO2017223428A1
    公开(公告)日:2017-12-28
    A composition comprising the following structure: (formula I) wherein Re represents a rhenium ion having a +1 charge; (formula II) represents an uncharged bidentate bicyclic ligand bonded to the rhenium (Re) by two ring nitrogen (N) atoms; and L is a neutral ligand independently selected from CO and neutral phosphine molecules, wherein at least one of the L groups is a CO molecule; and X- represents a non-coordinating monovalent anion; wherein (formula II) is unsubstituted or substituted on any of its two rings, and said neutral phosphine molecule may or may not contain a phosphorus atom as a ring phosphorus atom; provided that, if (formula II) is unsubstituted, then one or two of said L groups are selected from said neutral phosphine molecules, with the provision that at least one of the neutral phosphine molecules has a phosphorus atom as a ring phosphorus atom. Methods for treating cancer by administering the above complex are also disclosed.
    以下结构的组成物:(公式I),其中Re代表一个带有+1电荷的铼离子;(公式II)代表一个未带电的双齿双环配体,通过两个环上的氮(N)原子与铼(Re)结合;L是独立选择的电中性配体,选自CO和电中性磷化氢分子,其中至少一个L基团是CO分子;X-代表一个非配位的单价阴离子;(公式II)未取代或在其任一双环上进行取代,并且所说的电中性磷化氢分子可能含有也可能不含有作为环磷原子的磷原子;条件是,如果(公式II)未取代,则所说的L基团中有一个或两个选自所说的电中性磷化氢分子,并且至少有一个电中性磷化氢分子具有作为环磷原子的磷原子。还公开了通过施用上述复合物来治疗癌症的方法。
  • Metal-Organic Framework Catalysts and Their Use in Hydrocarbon Transformation
    申请人:Lillerud Karl-Petter
    公开号:US20080306315A1
    公开(公告)日:2008-12-11
    The invention relates to a porous heterogeneous catalyst material comprising frameworks of inorganic cornerstones connected by organic bridges, characterized in that as organic bridges are used ligands having a complexed catalytically active metal. The metals are preferably palladium and platinum. The ligands preferably contain nitrogen donor groups for complexing the catalytically active metal and carboxylate groups connecting to the inorganic cornerstones.
    这项发明涉及一种多孔的异质催化剂材料,其包括由无机基石通过有机桥连接而成的框架,其特征在于作为有机桥的配体是具有络合催化活性金属的。金属优选为钯和铂。配体优选包含氮供体基团以络合催化活性金属,并且连接到无机基石的羧基团。
  • METAL COMPLEXES FOR USE AS DOPANTS AND OTHER USES
    申请人:Ecole Polytechnique Federale de Lausanne (EPFL)
    公开号:US20160233439A1
    公开(公告)日:2016-08-11
    The invention relates to electrochemical devices comprising complexes of cobalt comprising at least one ligand with a 5- or six membered, N-containing heteroring. The complex are useful as p- and n-dopants, as over of electrochemical devices, in particular in organic semiconductors. The complexes are further useful as over-discharge prevention and overvoltage protection agents.
    本发明涉及一种包含钴配合物的电化学器件,该配合物至少包含一种含有5或6个成员的N-含杂环配体。该配合物可用作p-和n-掺杂剂,用于电化学器件,特别是有机半导体中。此外,该配合物还可用作过放电防止和过电压保护剂。
  • Metal complexes for use as dopants and other uses
    申请人:Ecole Polytechnique Federale de Lausanne (EPFL)
    公开号:US10038150B2
    公开(公告)日:2018-07-31
    The invention relates to electrochemical devices comprising complexes of cobalt comprising at least one ligand with a 5- or six membered, N-containing heteroring. The complex are useful as p- and n-dopants, as over of electrochemical devices, in particular in organic semiconductors. The complexes are further useful as over-discharge prevention and overvoltage protection agents.
    本发明涉及由钴络合物组成的电化学装置,钴络合物包含至少一个配体,该配体具有 5 个或 6 个含 N 的杂环。这些配合物可作为 p 和 n 掺杂剂,用于电化学装置,特别是有机半导体。这些配合物还可用作防止过放电和过压保护剂。
  • Rhenium complexes and methods of use for treating cancer
    申请人:CORNELL UNIVERSITY
    公开号:US10973849B2
    公开(公告)日:2021-04-13
    A composition comprising the following structure: (formula I) wherein Re represents a rhenium ion having a +1 charge; (formula II) represents an uncharged bidentate bicyclic ligand bonded to the rhenium (Re) by two ring nitrogen (N) atoms; and L is a neutral ligand independently selected from CO and neutral phosphine molecules, wherein at least one of the L groups is a CO molecule; and X− represents a non-coordinating monovalent anion; wherein (formula II) is unsubstituted or substituted on any of its two rings, and said neutral phosphine molecule may or may not contain a phosphorus atom as a ring phosphorus atom; provided that, if (formula II) is unsubstituted, then one or two of said L groups are selected from said neutral phosphine molecules, with the provision that at least one of the neutral phosphine molecules has a phosphorus atom as a ring phosphorus atom. Methods for treating cancer by administering the above complex are also disclosed.
    一种由以下结构组成的组合物:(式 I) 其中 Re 代表具有 +1 电荷的铼离子;(式 II) 代表通过两个环氮 (N) 原子与铼 (Re) 键合的无电荷双齿双环配体;以及 L 是独立选自 CO 和中性膦分子的中性配体,其中至少一个 L 基团是 CO 分子;以及 X- 代表非配位一价阴离子;其中(式 II)在其两个环的任何一个上未被取代或被取代,所述中性膦分子可以含有或不含有作为环磷原子的磷原子;条件是,如果(式 II)未被取代,则所述 L 基团中的一个或两个选自所述中性膦分子,并规定至少一个中性膦分子具有作为环磷原子的磷原子。还公开了通过施用上述复合物治疗癌症的方法。
查看更多

同类化合物

钼,四羰基(1,10-亚铁试剂(邻二氮杂菲)-kN1,kN10)-,(OC-6-22)- 钌(2+)高氯酸酯-1,10-亚铁试剂(邻二氮杂菲)(1:2:3) 邻菲罗啉 胶原脯氨酸羟化酶抑制剂-1 石杉碱乙 氯化-1,10-菲咯啉水合物 氯(甘氨酰酸基)(1,10-菲咯啉)铜(II) 新铜试剂 新亚铜灵盐酸 吡嗪并[2,3-f]的[1,10]菲咯啉 吡嗪并[2,3-f][1,10]菲罗啉-2,3-二甲腈 吡喃联氮基[1,2,3,4-lmn][1,10]菲并啉二正离子(8CI,9CI) 双(2,2-二吡啶)-(5-氨基邻二氮杂菲)双(六氟磷酸)钌 二苯基1,10-亚铁试剂(邻二氮杂菲)-4,7-二磺酸酯 二氯(1,10-菲咯啉)铜(II) 二氯(1,10-亚铁试剂)铂(II) 二氯(1,10-亚铁试剂)钯(II) 二吡啶并[3,2-a:2',3'-c]吩嗪 二(菲咯啉)(二吡啶并吩嗪)钌(II) 二(氰基)二(1,10-菲咯啉)-铁 二(1,10-菲咯啉)铜 三菲咯啉钴(III) 三氟甲基(1,10-菲咯啉)铜(I)[Trifluoromethylator®] 三-(1,10-菲咯啉)钌 三(1,10-菲咯啉)硫酸铁 丁夫罗林 N-乙基-7,10-二氢-8-硝基-7-氧代-N-乙基-1,10-菲罗啉-3-甲酰胺 N-[4-(苯并[b][1,7]菲并啉-7-基氨基)-3-(甲基氨基)苯基]甲磺酰胺盐酸(1:1) B-1,10-菲罗啉-5-基硼酸 B-1,10-菲罗啉-2-基-硼酸 9-溴-1-甲基-1,10-菲咯啉-2-酮 9-氯-1-甲基-1,10-菲咯啉-2-酮 8,15-二去氢-17-甲基-石松定-1(18H)-酮 6-(2-碘苯基)亚氨基-1,10-菲咯啉-5-酮 6,7-二氢-5,8-二甲基二苯并(b,j)(1,10)菲咯啉 6,6'-二氰基-7,7'-二乙氧基-3,3'-(乙烷-1,2-二基)-5,5'-二苯基-2,2'-联-1,8-二氮杂萘 5-醛基-1,10-菲咯啉 5-羧基-1,10-菲罗啉 5-羟基-1,10-菲咯啉 5-硝基邻二氮杂菲-2,9-二羧酸一水合物 5-硝基-6氨基-1,10-邻菲罗啉 5-硝基-1,10-菲罗啉硫酸亚铁 5-硝基-1,10-菲咯啉亚铁高氯酸盐 5-硝基-1,10-菲咯啉 5-甲氧基-2-(三氟甲基)-1,10-菲并啉-4(1H)-酮 5-甲氧基-1H-1,10-菲咯啉-4-酮 5-甲基-1,10-菲咯啉亚铁高氯酸盐 5-甲基-1,10-菲咯啉亚铁高氯酸盐 5-甲基-1,10-菲咯啉 5-溴-1,10-菲罗啉